Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current Treatment Options in Cardiovascular Medicine|August 28, 2013
Inflammation and atherosclerosis: disease modulating therapiesMahesh J Patel, Michael A Blazing
Journal of Cardiovascular Risk|December 13, 2002
Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapyW Lane Duvall, Michael A Blazing, Shilpa Saxena, et al.
The American Journal of Cardiology|June 15, 2004
Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemiaChristie M Ballantyne, Michael A Blazing, Thomas R King, et al.
The American Journal of Cardiology|February 12, 2019
Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)Abhinav Sharma, Jie-Lena Sun, Yuliya Lokhnygina, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 22, 2010
Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?Melissa H Kong, Linda K Shaw, Christopher O'Connor, et al.
Journal of the American Society of Nephrology : JASN|May 17, 2017
Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney FunctionJohn W Stanifer, David M Charytan, Jennifer White, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 24, 2005
Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapyRichard E Waters, David E Kandzari, Harry R Phillips, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 7, 2009
Management of hyperlipidemia in older adultsKaren P Alexander, Michael A Blazing, Robert S Rosenson, et al.
Journal of the American College of Cardiology|October 8, 2021
Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-ITKazuma Oyama, Robert P Giugliano, Michael A Blazing, et al.
Pageof 6